Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
RespireRx Phamaceuticals
RespireRx Pharmaceuticals discovers and develops drug therapies for sleep apnea and CNS disorders.
Sector
Subsector
Location
total rounds
total raised
Acadia Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc.
Sector
Subsector
Keywords
Location
total rounds
total raised
Chase Pharmaceuticals
Chase Pharmaceuticals develops improved treatments for CNS diseases.
Sector
Subsector
Location
total rounds
total raised
Avanir Pharmaceuticals
Avanir Pharmaceuticals is a biopharmaceutical company that provides innovative medicines to patients with central nervous system disorders.
Sector
Subsector
Location
total rounds
total raised
M&A Details1
Financials
Funding Rounds6
Number of Funding Rounds
Money Raised
Their latest funding was raised on 01.01.2017. Their latest round Venture - Series Unknown
Vertical GP-5
Company
count Of Investments
count Of Exists
Broadview Ventures
Broadview Ventures invests in technology solutions for cardiovascular and neurovascular diseases.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Co-Investors
Investors2
Number of lead investors
Number of investors
Vertical GP-5
Company
count Of Investments
count Of Exists
Broadview Ventures
Broadview Ventures invests in technology solutions for cardiovascular and neurovascular diseases.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Frederick Jones
current job
People
Founders2
Sven M. Jacobson
Sven is a co-founder of Remedy Pharmaceuticals. He has been the CEO of Remedy since 2007 and serves on the company’s board of directors. He is the inventor of CIRARA’s formulation and the company’s MPD technology. Sven has over 20 years of senior management experience. Sven is a Partner at Carrot Capital Healthcare Ventures and co-founder and board member of Critical Diagnostics, a diagnostics company focused on cardiac disease. Sven was also a co-founder of Access Scientific, which was acquired by Endeavour Capital, as well as Cure Therapeutics, and St. Camillus Medical. He has experience in the neurocritical care, neurology, cardiovascular, orthopedic, and vascular access fields. Sven’s international experience includes prior executive management positions at Leisureplanet (Belgium) and Rennies Travel and Financial Services Group (South Africa), and current board membership of Critical Diagnostics Ltd. (Ireland). Sven received his Bachelor of Science Engineering (BSc Eng) and MBA degrees from the University of the Witwatersrand in Johannesburg, South Africa.
current job
organization founded
Sven M. Jacobson
David M. Geliebter
David is a co-founder of Remedy Pharmaceuticals. A serial entrepreneur, he has over 50 years of experience successfully starting and growing several businesses. David founded and ran the Carson Group, a global financial information and advisory company, which was sold to Thomson Corporation in 2000. He was also a founding principal and President of Evolution Capital, a healthcare investment banking firm. Prior to that, David founded Harvard Capital, a financial communications company that was acquired by WPP Group in 1986. David is the Managing Partner of Carrot Capital Healthcare Ventures and founder and board member of Critical Diagnostics, a diagnostics company focused on cardiac disease. David is a past winner of the Ernst & Young Entrepreneur of the Year Award.
current job
organization founded
David M. Geliebter
Employee Profiles4
Ann Tunstall
VP, Regulatory And Clinical Operations